The present invention relates generally to compounds having melatonin receptor activities and in particular to substituted 2-amidotetralin derivatives; to pharmaceutical preparations comprising such compounds; and to methods for using these compounds as therapeutic and diagnostic reagents.
本发明涉及一般具有
褪黑激素受体活性的化合物,特别是取代的2-胺基四环烯衍
生物;包括这些化合物的药物制剂;以及使用这些化合物作为治疗和诊断试剂的方法。